Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asfotase Alfa in Children with Hypophosphatasia (HPP)
NCT00952484Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Sep 2009
- Primary completion
- Jul 2010
- Modality
- Replacement Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of asfotase alfa in hypophosphatasia (HPP), sponsored by Alexion Pharmaceuticals. Started Sep 2009; status: completed.
02
Drugs
asfotase alfa
03
Conditions
hypophosphatasia (HPP)
Beyond the preview
Go deeper on NCT00952484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00952484.